Skip to content
Search

Latest Stories

New standards for chief pharmacists released

GPhC updates standards for chief pharmacists
The new standards apply to all chief pharmacists, regardless of the setting they work in

The new standards apply to all chief pharmacists, regardless of the setting they work in 

Following a review of feedback from last year's consultation on draft proposals, the General Pharmaceutical Council (GPhC) has published new standards for chief pharmacists.

The standards outline responsibilities, knowledge, conduct, and performance required by a chief pharmacist to support their organisation and its staff to deliver safe and effective pharmacy services.


The regulatory body observed that the updated standards reflect new legislation removing the threat of criminal sanctions for inadvertent preparation and dispensing errors by pharmacy staff working in hospitals and similar settings.

Given that these protections already apply to pharmacy staff in registered pharmacies, this new legislation aims to standardize practices across the sector, thereby encouraging the reporting of incidents, and subsequently learning from errors.

To benefit from the defences, the hospital (or relevant setting) requires a chief pharmacist or equivalent in post, who must be a registered pharmacist with the appropriate skills, training, and experience.

The chief pharmacist must also meet the standards, which include:

  • Providing strategic and professional leadership.
  • Developing a workforce with the right skills, knowledge, and experience.
  • Delegating responsibly and make sure there are clear lines of accountability.
  • Maintaining and strengthening governance to ensure safe and effective delivery of pharmacy services.

The new standards apply to all chief pharmacists, regardless of the setting they work in.

Louise Edwards, chief strategy officer at GPhC, described the development of the chief pharmacist standards as the first part of their programme to strengthen pharmacy governance.

“The programme aims to provide clarity around how pharmacies are organised and managed to help ensure patients and the public continue to receive safe and effective pharmacy care,” he explained.

Edwards acknowledged that while chief pharmacists often do not provide care directly themselves, their actions have an impact on patient care and people’s confidence in pharmacy.

“The new standards are helping to strengthen assurance in a critical leadership role, and support governance to make sure patients and the public receive safe and effective care,” he added.

The GPhC received 158 responses to the consultation on the draft standards, 132 from individuals and 26 from organisations.

Most respondents showed agreement with the proposals, with 79 per cent stating that the changes would strengthen and maintain pharmacy governance.

While 68 per cent of respondents said the new standards would provide a governance framework supporting staff to report preparation and dispensing errors, 67 per cent agreed that the reporting of errors would help staff learn from those errors.

In addition to the consultation, the GPhC hosted a webinar on the standards and organised two public and patient forums.

After taking into account the feedback, GPhC has made some changes to the standards, including adding a requirement for chief pharmacists to ensure that staff feel confident and supported when challenging behaviours such as discrimination, bullying, and harassment.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less